The experience of using the fingolimod for patients with relapsing-remitting multiple sclerosis
Автор: Sokolova A.A., Anischenko L.I., Vashkulatova E.A., Reikhert L.I., Kicherova O.A.
Журнал: Научный форум. Сибирь @forumsibir
Рубрика: Медицина
Статья в выпуске: 1 т.3, 2017 года.
Бесплатный доступ
The analysis of results of treatment of 22 patients with multiple sclerosis medicine of immunomodulatory action - fingolimod was conducted. The high efficiency of the medicine in the prevention of exacerbations of MS, progression of disability, good tolerability and safety was identified.
Multiple sclerosis, fingolimod, immunomodulatory drugs
Короткий адрес: https://sciup.org/140220467
IDR: 140220467
Статья научная
